1. Home
  2. COEP vs ANY Comparison

COEP vs ANY Comparison

Compare COEP & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ANY
  • Stock Information
  • Founded
  • COEP 2017
  • ANY N/A
  • Country
  • COEP United States
  • ANY United States
  • Employees
  • COEP 7
  • ANY N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ANY Finance: Consumer Services
  • Sector
  • COEP Health Care
  • ANY Finance
  • Exchange
  • COEP Nasdaq
  • ANY Nasdaq
  • Market Cap
  • COEP 22.3M
  • ANY 25.5M
  • IPO Year
  • COEP N/A
  • ANY N/A
  • Fundamental
  • Price
  • COEP $9.27
  • ANY $1.09
  • Analyst Decision
  • COEP
  • ANY Strong Buy
  • Analyst Count
  • COEP 0
  • ANY 1
  • Target Price
  • COEP N/A
  • ANY $3.00
  • AVG Volume (30 Days)
  • COEP 1.0M
  • ANY 672.6K
  • Earning Date
  • COEP 11-13-2024
  • ANY 03-12-2025
  • Dividend Yield
  • COEP N/A
  • ANY N/A
  • EPS Growth
  • COEP N/A
  • ANY N/A
  • EPS
  • COEP N/A
  • ANY N/A
  • Revenue
  • COEP N/A
  • ANY $21,657,000.00
  • Revenue This Year
  • COEP N/A
  • ANY N/A
  • Revenue Next Year
  • COEP N/A
  • ANY N/A
  • P/E Ratio
  • COEP N/A
  • ANY N/A
  • Revenue Growth
  • COEP N/A
  • ANY 38.44
  • 52 Week Low
  • COEP $2.31
  • ANY $0.67
  • 52 Week High
  • COEP $13.58
  • ANY $2.73
  • Technical
  • Relative Strength Index (RSI)
  • COEP 75.88
  • ANY 49.47
  • Support Level
  • COEP $6.22
  • ANY $0.98
  • Resistance Level
  • COEP $10.00
  • ANY $1.08
  • Average True Range (ATR)
  • COEP 1.79
  • ANY 0.09
  • MACD
  • COEP 0.43
  • ANY 0.01
  • Stochastic Oscillator
  • COEP 90.51
  • ANY 67.27

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: